Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 1
2019 5
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections.
Mateu-Borrás M, Zamorano L, González-Alsina A, Sánchez-Diener I, Doménech-Sánchez A, Oliver A, Albertí S. Mateu-Borrás M, et al. Among authors: sanchez diener i. Front Cell Infect Microbiol. 2022 Jan 12;11:816356. doi: 10.3389/fcimb.2021.816356. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35145924 Free PMC article.
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants.
Fraile-Ribot PA, Zamorano L, Orellana R, Del Barrio-Tofiño E, Sánchez-Diener I, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas Study Group. Fraile-Ribot PA, et al. Among authors: sanchez diener i. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02165-19. doi: 10.1128/AAC.02165-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31740559 Free PMC article.
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
Del Barrio-Tofiño E, Zamorano L, Cortes-Lara S, López-Causapé C, Sánchez-Diener I, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas study Group. Del Barrio-Tofiño E, et al. Among authors: sanchez diener i. J Antimicrob Chemother. 2019 Jul 1;74(7):1825-1835. doi: 10.1093/jac/dkz147. J Antimicrob Chemother. 2019. PMID: 30989186
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy.
Barceló I, Cabot G, Palwe S, Joshi P, Takalkar S, Periasamy H, Cortés-Lara S, Zamorano L, Sánchez-Diener I, Moya B, Bhagwat S, Patel M, Oliver A. Barceló I, et al. Among authors: sanchez diener i. J Antimicrob Chemother. 2021 Sep 15;76(10):2546-2557. doi: 10.1093/jac/dkab213. J Antimicrob Chemother. 2021. PMID: 34219168
Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Rodriguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A. Sánchez-Diener I, et al. Clin Microbiol Infect. 2020 Mar;26(3):351-357. doi: 10.1016/j.cmi.2019.06.034. Epub 2019 Jul 6. Clin Microbiol Infect. 2020. PMID: 31288102 Free article.
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
Del Barrio-Tofiño E, Sánchez-Diener I, Zamorano L, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI. Del Barrio-Tofiño E, et al. Among authors: sanchez diener i. J Antimicrob Chemother. 2019 Nov 1;74(11):3217-3220. doi: 10.1093/jac/dkz346. J Antimicrob Chemother. 2019. PMID: 31430372 Free article.
14 results